In the multicenter, open-label, 28-week GRECO trial, ... single-use auto-injector pen for patients with severe eosinophilic asthma, according to a company press release.

Patients who have an unlabeled pen should contact Sedgwick at 1-877-643-8438 to ... one batch of its 100 units/mL insulin glargine injection pens due to the potential for missing labels, ...

The Food and Drug Administration (FDA) announced that multi-dose diabetes pen devices intended for single patient use only are now required to add additional label warnings prohibiting the sharing ...

AbbVie GK, Eisai Co. and EA Pharma Co. have debuted the HUMIRA Pen, an auto-injector pen meant to help simplify self-injection. MCKNIGHT’S LONG-TERM CARE NEWS MCKNIGHT’S SENIOR LIVING ...

WILMINGTON, Del. -- AstraZeneca has received regulatory approval for a single-use pen injector designed to improve glycemic control in patients with type 2 diabetes – a disease with soaring ...

Insulin Glargine (Insulin glargine-yfgn) Injection, 3mL prefilled pens, packaged in cartons of five pens, NDC number 49502-394-75, batch number BF21002895, expires August 2023.

New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for an undisclosed Pfizer drug, adding 13% to its shares value on Nasdaq.

New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for an undisclosed Pfizer drug, adding 13% to its shares value on Nasdaq.